Eubacterium coprostanoligenes

Information

Microbe Identification

Eubacterium coprostanoligenes

Microbe id: PMDBM2021530
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Eubacterium coprostanoligenes [290054]
Taxonomy Genus: Eubacterium [1730]
Taxonomy Family: Eubacteriaceae [186806]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Eubacterium coprostanoligenes

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Eubacterium coprostanoligenes


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Eubacterium coprostanoligenes distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Eubacterium coprostanoligenes in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Eubacterium coprostanoligenes

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗-3.49423647888876mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.23923822468559mNGS
Hypertension PRJNA509999🔗-2.58716216550567mNGS
Depression, Postpartum PRJNA637228🔗-3.8620446443035816S
Arthritis, Juvenile PRJNA562467🔗-4.2197654232740416S
Diabetes Mellitus, Type 2 PRJNA588353🔗4.7058650353330316S
Diarrhea PRJNA317326🔗-4.4381972545877116S
Diarrhea PRJEB14038🔗3.39398189971627mNGS
Colorectal Neoplasms PRJEB46665🔗-4.4671274716097416S
Colorectal Neoplasms PRJNA284542🔗-4.4455633410612516S
Colorectal Neoplasms PRJNA731589🔗-3.74887743922898mNGS
Colorectal Neoplasms PRJNA888860🔗-3.53417764465119mNGS
Colorectal Neoplasms PRJEB70916🔗-3.49752099523611mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.23903399240793mNGS
Colorectal Neoplasms PRJNA1138893🔗-3.19491535012345mNGS
Colorectal Neoplasms PRJNA763023🔗-3.04748104467994mNGS
Colorectal Neoplasms PRJEB53415🔗4.3615782974636416S
Lupus Erythematosus, Systemic PRJEB52971🔗-4.291776382456716S
Tuberculosis PRJNA795263🔗-4.6515177257271916S
Diabetes Mellitus, Type 1 PRJNA604850🔗-3.13307000551106mNGS
Parkinson Disease PRJNA762484🔗3.26581503997017mNGS
Colitis, Ulcerative PRJNA917086🔗-4.7899467457007616S
Colitis, Ulcerative PRJNA804422🔗-4.3953303842136316S
Colitis, Ulcerative PRJNA993675🔗-3.42732225911848mNGS
Colitis, Ulcerative PRJNA398089🔗-2.58586858089006mNGS
Campylobacter Infections PRJNA660443🔗-3.21351539643885mNGS
Spinal Cord Injuries PRJNA861246🔗-4.2159500990881516S
Carcinoma, Hepatocellular PRJNA872871🔗-4.1053409381751416S
Celiac Disease PRJNA890948🔗-4.3050429524525916S
Spondylarthritis PRJNA342486🔗-4.3703095537096516S
Caliciviridae Infections PRJNA788674🔗-4.7783843960931616S
Hepatolenticular Degeneration PRJNA1038771🔗-4.1858867492200516S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.7524531291958916S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-4.5029546654295516S
Prostatic Neoplasms PRJNA762994🔗-4.6106679461984516S
Emergence Delirium PRJNA797529🔗3.9893420347322916S
Hidradenitis Suppurativa PRJEB43835🔗-4.515751018445416S
Crohn Disease PRJNA917086🔗-4.7861835801672416S
Crohn Disease PRJEB6172🔗-4.4848583144734316S
Crohn Disease PRJNA793776🔗-3.5437808549444mNGS
Crohn Disease PRJNA993675🔗-3.35429627623824mNGS
Crohn Disease PRJNA398089🔗2.52028425457886mNGS
Mastitis PRJNA667141🔗-4.3005452806261116S
Polycystic Ovary Syndrome PRJEB38647🔗-4.4536733021252316S
Cholestasis PRJNA478781🔗-4.1192267310286116S
Moyamoya Disease PRJNA917033🔗-4.2138790437215416S
Dermatitis, Atopic PRJEB45443🔗3.24654885696785mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗-3.25647863311382mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-3.11589055720627mNGS
Anorexia PRJNA674716🔗-3.63649618119266mNGS
Depression PRJNA776170🔗-4.0701992760893116S
Autoimmune Diseases of the Nervous System PRJNA586763🔗5.0182104328068916S
Growth Hormone-Secreting Pituitary Adenoma PRJNA743650🔗2.9363322628977516S
Neuroblastoma PRJEB63351🔗2.83273473651656mNGS
Hematologic Neoplasms PRJNA777832🔗-4.7418451891125916S
Irritable Bowel Syndrome PRJNA637763🔗-3.9847940164571716S
Irritable Bowel Syndrome PRJEB37924🔗-2.90673934887683mNGS
Epilepsy PRJNA506309🔗-4.5137720173365416S
Clostridium Infections PRJNA648321🔗-3.09331506948103mNGS
Cholelithiasis PRJNA999028🔗-3.5695728139337mNGS
Cystic Fibrosis PRJNA314903🔗-3.16110892342245mNGS
Anti-N-Methyl-D-Aspartate Receptor Encephalitis PRJNA764676🔗-4.4457767346634316S
Obesity PRJNA1125836🔗3.5926830793253mNGS
HIV Infections PRJNA810567🔗-4.3434016103111216S
Inflammatory Bowel Diseases PRJNA1028828🔗-4.5988772138203216S
Inflammatory Bowel Diseases PRJNA993675🔗-3.42747071581196mNGS
Rhinitis, Allergic PRJNA692671🔗-4.4464610347803216S
Renal Insufficiency, Chronic PRJNA659589🔗-3.959616133245816S
Renal Insufficiency, Chronic PRJNA562327🔗-3.8638678898594316S
Mucocutaneous Lymph Node Syndrome PRJNA595748🔗-4.5288982731961416S
Multiple Sclerosis PRJEB34168🔗-4.1209237337597816S
Fibromyalgia PRJEB80379🔗-3.61545613180127mNGS
Breast Neoplasms PRJNA658160🔗-3.5718648078564716S
COVID-19 PRJNA624223🔗-3.91696936582691mNGS
COVID-19 PRJNA689961🔗-3.56372644509163mNGS
COVID-19 PRJNA769052🔗4.6538476408997116S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Eubacterium coprostanoligenes



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Eubacterium coprostanoligenes



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Eubacterium coprostanoligenes

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Eubacterium coprostanoligenes


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Eubacterium coprostanoligenes



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Eubacterium coprostanoligenes

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Eubacterium coprostanoligenes

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Eubacterium coprostanoligenes

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Eubacterium coprostanoligenes



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Eubacterium coprostanoligenes


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Eubacterium coprostanoligenes


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?